Skip to main content

Advertisement

Table 1 Characteristics of the study cohort at the beginning of follow-up

From: Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study

  Epilepsy Not epilepsy p-value
Number of patients 21 1099  
Men (%) 18 (86 %) 760 (69 %) 0.10
Age (median, IQR) 54 (45–59) 57 (50–64) 0.04
Cirrhosis etiology    0.22
 Alcohol alone (%) 16 (76 %) 634 (58 %)  
 Hepatitis C alone (%) 1 (5 %) 147 (13 %)  
 Other (%) 4 (19 %) 318 (29 %)  
Diabetes (%) 4 (19 %) 256 (23 %) 0.65
History of HE before randomization (%) 4 (19 %) 251 (23 %) 0.68
MELD score (median, IQR) 7.9 (4.6–11.3) 11.4 (8.1–14.4) 0.02
Sodium, mmol/L (median, IQR) 136 (133–138) 137 (134–139) 0.34
Albumin, g/L (median, IQR) 33 (29–37) 33 (29–37) 0.68
Lactulose, any dose (%) 14 (19 %) 330 (30 %) 0.28
Rifaximin, any dose (%) 0 (0 %) 27 (2 %) 0.45
Benzodiazepine/barbiturates, any dose (%) 2 (10 %) 95 (9 %) 0.89
  1. IQR interquartile range, 25th percentile to 75th percentile